You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

The prize is awarded to the companies that made the best use of the capital markets

read more 

CORPORATE

Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D

Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn

read more 

CORPORATE

Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme

Goal is to improve access to replacement therapies for coagulation disorders in Europe

read more 
  1. CORPORATE - 16-02-2018

    Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

    The prize is awarded to the companies that made the best use of the capital markets

    read more 
  2. CORPORATE - 14-02-2018

    Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D

    Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn

    read more 
  3. CORPORATE - 10-01-2018

    Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme

    Goal is to improve access to replacement therapies for coagulation disorders in Europe

    read more 
  4. EVENTS - 09-11-2017

    Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

    This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

    read more 

Pages

For more information please contact: pressoffice@kedrion.com